Your weekly roundup of the latest news from Drug Topics®.
Lenacapavir was approved with the FDA's Breakthrough Therapy Designation.
In the midst of an opioid epidemic, CBD may help patients experiencing opioid withdrawal symptoms find relief.
Research tells a different story than recent news headlines.
The Medicare Part D Senior Savings Model—a CMS effort to test $35 copays for insulin—led to lowered total costs for beneficiaries.
The COVID-19 vaccine rate for teenagers lags behind vaccination rates for adults. Does parental hesitancy for vaccines in general play a role?
Read more
Exploring Challenges, Opportunities for Community Pharmacists in Tobacco Cessation
April 24th 2024By addressing integration barriers associated with implementing tobacco cessation programs in the community pharmacy, community pharmacists can “significantly impact public health by increasing access to effective cessation support,” wrote investigators.